Innovative Surgical Devices for Human Vision Disorders (Technical Insights)


Regular Price: USD 4,950.00

Special Price USD 3,465.00

30% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,465.00


Be the first to review this product

The research service titled "Innovative Surgical Devices for Human Eye Disorders" covers at length the advancements and trends in the accommodative intraocular lenses, implantable retinal devices, and laser surgery devices domains. This report also profiles some of the notable technology adoption factors influencing decision-making process involved in choosing best ophthalmological surgical devices for this sector.

Table of Contents

Innovative Surgical Devices for Human Vision Disorders (Technical Insights), Executive SummaryScope and Methodology PreviewScope of the Research ServiceResearch MethodologyTrends in Surgical Devices Applicable to the Ophthalmologic IndustrySnapshot of Current TrendsFuture Trends AnalysisInnovative Surgical Devices for Human Vision Disorders (Technical Insights), Technology Adoption Factor and Impact AnalysisTechnology PrimerSneak Preview of Eye Disease ClustersOphthalmic Surgical Product Portfolio for Eye ConcernsInsights into Technology Adoption FactorsTechnology Drivers and RestraintsTechnology ChallengesStrategic Assessment and Analyst InsightsSWOT Matrix for Surgical Devices Used in Ophthalmology SectorFuture Directions for Key Surgical Devices Used in Vision Correction--Technology RoadmapStrategic RecommendationsInnovative Surgical Devices for Human Vision Disorders (Technical Insights), Global Assessment of Notable Technology InnovationsAccommodative Intraocular LensFully Diffractive Multifocal IOL for Cataract--USA Functional Vision with a Promising Dual Optic Accommodating IOL--USAMost Frequently Implanted Apodized Diffractive IOL--Viable Option for Improving Vision Post-Cataract Surgery--USAHydrophilic Acrylic IOLs Designed to be Free of Spherical Aberration--USAImplantable Multifocal IOL Designed to be Compatible with Real Microincision--GermanyAccommodating and Adjustable IOLs for Treating Cataract and Reading Far-Sightedness Conditions--NetherlandsContact Lenses to Measure Intraocular Pressure and Study Glaucoma--USAPhotochromic IOL Recognized to be Outpacing Aspheric IOL under Mesopic Conditions--MexicoSuggestions for Achieving Enhanced Refractive Outcomes--USAImplantable Retinal DevicesEpimacular Brachytherapy Device--A Potential Treatment Option for Wet AMD--USAEx-PRESS Miniature Glaucoma Shunt to Reduce Intraocular Pressure--IsraelBioengineered Hydrogel Material for Renewing Near Vision--USATrabectome for Minimally Invasive Surgical Management of Glaucoma--USANoninvasive Robotically Controlled Treatments for Neovascular Diseases of the Eye--USATelescope Prosthesis for End-Stage Macular Degeneration--USAVision Screening Device for Detection of Diabetes-Induced Retinal Metabolic Stress--USAPolymer-Based Corneal Implants for Better Eyesight--GermanyTiny Surgical Implant That Helps Prevent Complete Vision Loss--USALaser Surgery DevicesSOLX 790 Laser--Next-Generation Glaucoma Treatment Platform--USASemi-Automated Pattern Generation Technique for Proliferative Diabetic Retinopathy Laser Treatment--SingaporeAdvanced Refractive Laser Surgery System Receives FDA Clearance--USAOverview of Surgical Options Used to Treat Retinal Detachment--USAInnovative Surgical Devices for Human Vision Disorders (Technical Insights), Patents and Database of Key Industry ParticipantsPatentsRevolutionizing Cataract Products--Key PatentsAdvanced Refractive Products--Key PatentsGlaucoma Treatment Devices--Key PatentsCorneal and Retinal Care Products--Key PatentsGlossary and Database of Key Industry ParticipantsGlossary of TermsCorporate ParticipantsAcademic ParticipantsInnovative Surgical Devices for Human Vision Disorders (Technical Insights), Decision Support DatabaseDecision Support Database TablesGovernment Healthcare Expenditure--World (2002 to 2012)Total Healthcare Expenditure--World (2002 to 2012)Private Healthcare Expenditure--World (2002 to 2012)Diabetes Incidence--World (2002 to 2012)Number of Hospitals--World (2002 to 2012)

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.